Nifty 50
- TCS₹2,452.7079.70 (3.36%)
- Bajaj Finance₹1,078-66.80 (-5.84%)
- Grasim Industries₹3,323103.00 (3.20%)
- Bajaj Finserv₹2,008.90-77.10 (-3.70%)
- Hindalco Industries₹1,059.6032.60 (3.17%)
- Trent₹2,997-110.10 (-3.54%)
- Mahindra & Mahindra₹3,50296.00 (2.82%)
- ICICI Bank₹1,421-36.50 (-2.50%)
- HCL Technologies₹1,356.6021.60 (1.62%)
- Jio Financial ₹256.80-6.30 (-2.39%)
- SBI₹1,097.2012.20 (1.12%)
- Shriram Finance₹1,115-26.00 (-2.28%)
- Infosys₹1,175.1010.10 (0.87%)
- Axis Bank₹1,238-18.00 (-1.43%)
- Hindustan Unilever₹2,09616.50 (0.79%)
- Titan Company₹4,941-57.00 (-1.14%)
- Wipro₹187.531.41 (0.76%)
- Tata Steel₹187.55-1.75 (-0.92%)
- Reliance Industries₹1,334.809.80 (0.74%)
- Cipla₹1,463.80-13.20 (-0.89%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Hester Biosciences Share Price
HESTERBIO
₹2,410.20
Hester Biosciences Performance
Price Movement
₹2401.00
₹2500.80
1 Year Performance
₹1239.30
₹2683.60
Markets Today
Historical Performance
Summary
As of 07-08-2026 17:01, Hester Biosciences Ltd. share price today is ₹0, with a change of ₹-2458.50 (-100.00%) from the previous close of ₹2458.5. The stock opened at ₹2484.7 and traded between ₹2401 and ₹2500.8, with a total traded volume of 5928 shares. The company has a market capitalization of ₹2070 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2683.6 and ₹1239.3, respectively.
Hester Biosciences Ltd. valuation metrics include a P/E ratio of 15.2, EPS of ₹67.57, and book value of ₹5.70. Profitability indicators show ROE of 15.44% along with a dividend yield of 0.5%. Hester Biosciences Ltd. has reported revenue of ₹325.74 Cr and net profit of ₹136.18 Cr.
Hester Biosciences Ltd. technical indicators include Day RSI at 60.04, Day MFI at 85.5, Day ADX at 52.1. Additional indicators include Commodity Channel Index (CCI) at 39.3 and Williams %R at -52.72. Momentum indicators show Day MACD at 87.5, Day MACD Signal Line at 98.23, DayATR at 126.91. Rate of Change indicators for Hester Biosciences Ltd. include ROC125 at 67.27 and ROC21 at 14.45.
Exponential moving averages include EMA5 at ₹2471.3, EMA10 at ₹2457.1, EMA12 at ₹2447.4, EMA20 at ₹2399.2, EMA26 at ₹2359.9, EMA50 at ₹2211.1, EMA100 at ₹2011.1, EMA200 at ₹1876.8. Simple moving averages include SMA5 at ₹2475.4, SMA10 at ₹2458.9, SMA20 at ₹2405.2, SMA30 at ₹2333.1, SMA50 at ₹2202.6, SMA100 at ₹1870.9, SMA150 at ₹1757.6, SMA200 at ₹1729.4.
Support levels for Hester Biosciences are placed at First Support ₹2427.73, Second Support ₹2373.57, Third Support ₹2339.93. Resistance levels are seen at First Resistance ₹2515.53, Second Resistance ₹2549.17, Third Resistance ₹2603.33. Hester Biosciences Ltd. shareholding pattern shows promoter holding at 53.73%, FII holding at 0.31%, DII holding at 0%, public holding at 45.95%.
Hester Biosciences Fundamentals
Hester Biosciences Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 72.66 | 93.71 | 70.35 | 64.58 | 63.49 |
| Operating Expense | 48.31 | 62.25 | 53.64 | 52.70 | 51.08 |
| Operating Profit | 24.35 | 31.46 | 16.72 | 11.88 | 12.41 |
| Depreciation | 4.92 | 3.68 | 2.21 | 2.20 | 2.16 |
| Interest | 1.36 | 4.09 | 0.90 | 1.27 | 0.90 |
| Tax | 5.04 | 8.49 | 3.97 | 2.67 | 2.45 |
| Net Profit | 14.71 | 26.38 | 10.67 | 7.21 | 7.84 |
Hester Biosciences Technicals
Hester Biosciences Ltd. EMA & SMA
₹2410.20
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Hester Biosciences Support and Resistance
Resistance
Support
Technical Indicators
Hester Biosciences Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 53.7 | 53.7 | 53.7 | 53.7 | 53.7 | 53.7 |
| FII | 0.9 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 45.4 | 45.7 | 45.7 | 45.8 | 45.9 | 46 |
Hester Biosciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.49 K | 6.12 K | 40.65% |
| Week | 11.39 K | 1.01 L | 11.31% |
| 1 Month | 16.28 K | 75.34 K | 21.61% |
| 6 Month | 6.76 K | 22.75 K | 29.72% |
Hester Biosciences SWOT Analysis
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Jim Slater's Zulu Principle (Discover Growth Stocks)
Relative Outperformance versus Industry over 1 Month
Affordable Stocks with High ROE and Momentum
Companies with high TTM EPS Growth
Growth Stars: Strongest Annual EPS Performers
Strong QoQ EPS Growth in recent results
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Hester Biosciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 14 Jul, 2026 | 11 | FINAL | 14 Jul, 2026 | Equity Share |
| 06 Aug, 2025 | 7 | FINAL | 06 Aug, 2025 | Equity Share |
| 22 Aug, 2024 | 6 | FINAL | Equity Share | |
| 13 Sep, 2023 | 8 | FINAL | Equity Share | |
| 11 Aug, 2022 | 10 | FINAL | Equity Share | |
| 05 Aug, 2021 | 10 | FINAL | Equity Share | |
| 27 Aug, 2020 | 6.6 | FINAL | Equity Share | |
| 18 Jul, 2019 | 7 | FINAL | Equity Share | |
| 09 Nov, 2018 | 2 | INTERIM | 12 Nov, 2018 | Equity Share |
| 30 Aug, 2018 | 2 | INTERIM | 31 Aug, 2018 | Equity Share |
Hester Biosciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹145 | ₹574.90 | ₹5.07 | ₹107 | ₹166.15 | ₹14.61 |
| % Change | -3.37% | 6.24% | 0.60% | 0.00% | -2.00% | 2.81% |
| Revenue TTM (₹ Cr) | - | - | ₹69.99 | - | ₹291.17 | ₹174.18 |
| Net Profit TTM (₹ Cr) | - | - | ₹-176.47 | - | ₹14.68 | ₹29.06 |
| PE TTM | 11.70 | - | -0.20 | 12.90 | 45.80 | 26.50 |
| 1 Year Return | 8.74 | 31.66 | 418 | -14.06 | 37.3 | 59.23 |
| ROCE | 34.19 | 3.56 | -56.37 | - | - | 17.36 |
Similar Stocks
MEDISTEP
Medistep Healthcare Ltd.
₹ 20.00
+0.00%
INFLUX
Influx Healthtech Ltd.
₹ 285.00
-2.31%
MOREPENLAB
Morepen Laboratories Ltd.
₹ 80.00
+0.73%
LYKALABS
Lyka Labs Ltd.
₹ 66.74
-2.00%
ACCPL
Accretion Pharmaceuticals Ltd.
₹ 181.00
+0.64%
SATKARTAR
Sat Kartar Life Ltd.
₹ 118.50
-0.96%
ONYX
Onyx Biotec Ltd.
₹ 45.40
-1.84%
VAISHALI
Vaishali Pharma Ltd.
₹ 7.95
-0.38%
BALAXI
Balaxi Pharmaceuticals Ltd.
₹ 24.27
+0.29%
QUESTLAB
Quest Laboratories Ltd.
₹ 89.90
-0.39%
ZENITHDRUG
Zenith Drugs Ltd.
₹ 42.00
-4.55%
ACCENTMIC
Accent Microcell Ltd.
₹ 543.00
+5.55%
SUNREST
Sunrest Lifescience Ltd.
₹ 40.50
+3.85%
MONOPHARMA
Mono Pharmacare Ltd.
₹ 7.85
-4.85%
VILINBIO
Vilin Bio Med Ltd.
₹ 44.05
+3.04%
REMUS
Remus Pharmaceuticals Ltd.
₹ 845.00
+4.25%
INFINIUM
Infinium Pharmachem Ltd.
₹ 219.50
+4.55%
SOTAC
Sotac Pharmaceuticals Ltd
₹ 94.90
+3.21%
JFLLIFE
JFL Life Sciences Ltd.
₹ 13.70
+4.58%
ZOTA
Zota Healthcare Ltd.
₹ 1261.50
+1.21%
BETA
Beta Drugs Ltd.
₹ 2361.20
-6.26%
PAR
Par Drugs & Chemicals Ltd.
₹ 99.15
-1.75%
SAKAR
Sakar Healthcare Ltd.
₹ 931.95
+1.33%
MEDIORG
Medicamen Organics Ltd.
₹ 27.05
+0.19%
FAQ's on HESTERBIO
What is the current share price of Hester Biosciences Ltd.?
What is the Market Capitalization of Hester Biosciences Ltd.?
What are the PE and PB ratios for Hester Biosciences Ltd.?
What is the 52-Week High and Low for Hester Biosciences Ltd.?
What is the current dividend yield for Hester Biosciences Ltd.?
Who are the major shareholders of Hester Biosciences Ltd.?
- Promoter
- Public
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Hester Biosciences Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Hester Biosciences Ltd.?
By signing up I certify terms, conditions & privacy policy